ACQUITY UPC² System

 4.0/5.0 (1 review)
  • Ease of use 3 out of 5
  • After sales service 4 out of 5
  • Value for money 5 out of 5
ACQUITY UPC² System

Related video

Play this video

Description

 

UPC²: Expanding the boundaries of LC and GC separations

UltraPerformance Convergence Chromatography™ (UPC²™) is a new category of separations science that makes the complex analysis...routine. This new technology marries the unrealized potential of SFC with Waters proven UPLC® technology and expertise in the management of fluids, temperature, and pressure. By varying mobile phase strength, pressure, temperature, and stationary phase with UPC², one can separate, detect and quantify structural analogs, isomers, enantiomeric and diasteriomeric mixtures – all compounds or samples that challenge today’s laboratories. Because CO2 is the primary mobile phase for UPC², the technique greatly reduces the use of toxic solvents.

ACQUITY UPC² System: Discover what's been missing from your analytical toolbox

With the ACQUITY UPC² System, scientists can now separate, analyze, and understand compounds that have challenged all other LC and GC technologies including:
•   Hydrophobic and chiral compounds
•   Lipids
•   Thermally-labile samples
•   Polymers

It's also the perfect complement to MS due to its low solvent load and high resolution, narrow peaks and fast separations.

System features:
•   Compressed carbon dioxide (CO2), the primary mobile phase, is less costly and less toxic than liquid mobile phases or carrier gases.
•   Variable volume injection delivers 0.5 µL to 10 µL as well as the ability to match column and injection volume with minimal sample loss and need to change loops.
•   Higher throughput and productivity allows you to analyze more samples per day with faster re-equilibration of columns and shorter cycle times, increasing laboratory productivity.
•   Co-solvent and column switching provides flexibility in method development for faster solvent screening and faster column screening.

Reviews

Christopher Howson


Status:


See all reviews
Member since 2013

Organization:
Novartis
Read more »
RATING: 4.0

  • 3 out of 5EASE OF USE
  • 4 out of 5AFTER SALES SERVICE
  • 5 out of 5VALUE FOR MONEY




Review date: 20 May 2013

Application Area: Pharmaceutical analysis
ACQUITY UPC² System

"The UPC2 system is Waters first attempt at a SFC system that is truly theirs rather than making use of inherited equipment from previous acquisitions. It fits nicely in amongst the Acquity family of instruments and makes use of pre-existing Acquity features which familiar users will be pleased with (SFC modules integrated into Acquity Console). Running the system through MassLynx is not only straight forward but provides an easy platform for MS integration. From my experiences the hardware has been performing very well and I would highly recommend this instrument to anyone looking to do high resolution/high throughput chiral or achiral analysis."

Feedback

Request info

To:Waters
From:
Please contact me / call me with the ACQUITY UPC² System,

I am looking to purchase in /

.
About you

Write a review

Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad 3 (All reviews published will be entered into the next drawing on May 31st 2013).

  
Your Email

 



Ease of use

After sales services

Value for money

WATCH:
The benefits of becoming a reviewer
Share your opinions...()
HINTS & TIPS
Give reasons for the star ratings you have awarded for each area.
Would you recommend this to a colleague?
What would you like to have known about equipment and consumables before you purchased?



Join 200,000 Scientists Online

Become a member for FREE access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today